{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T12:35:52Z","timestamp":1791722152056,"version":"4.3.4"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Adropin and preptin have recently been identified as peptide hormones that may mediate metabolic dysfunction and vascular injury. However, their clinical relevance in non-alcoholic steatohepatitis (NASH) remains unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim:<\/jats:title>\n                    <jats:p>To evaluate adropin and preptin levels and their association with carotid intima-media thickness (CIMT) in biopsy-proven NASH.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>\n                      Forty NASH patients and 30 healthy controls were enrolled in this study. All participants had no diabetes, hypertension, or hyperlipidemia. anthropometric, biochemical measurements and Doppler ultrasonography were performed. Statistical analyses included Student\u2019s\n                      <jats:italic toggle=\"yes\">t<\/jats:italic>\n                      -test, Mann\u2013Whitney U test, correlation analyses, and multivariate logistic regression.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      In the NASH group, mean CIMT was significantly higher than in controls (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.01). CIMT was not correlated with adropin and preptin levels (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.166 and\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.325, respectively). Serum adropin and preptin levels in NASH group were significantly lower than those in controls (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.02 and\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.35, respectively). Adropin levels were negatively correlated with body fat mass (\n                      <jats:italic toggle=\"yes\">r<\/jats:italic>\n                      = \u22120.383,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.02) and body fat percentage (\n                      <jats:italic toggle=\"yes\">r<\/jats:italic>\n                      = \u22120.349,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.03), while preptin showed no correlations with body fat parameters. Furthermore, adropin and preptin levels exhibited moderate negative correlations with steatosis grade (\n                      <jats:italic toggle=\"yes\">r<\/jats:italic>\n                      = \u22120.451,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.002 and\n                      <jats:italic toggle=\"yes\">r<\/jats:italic>\n                      = \u22120.376,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.008, respectively), necroinflammatory activity (NAI) (\n                      <jats:italic toggle=\"yes\">r<\/jats:italic>\n                      = \u20130.275,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.04 and\n                      <jats:italic toggle=\"yes\">r<\/jats:italic>\n                      = \u20130.387,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.03, respectively), and weak, non-significant correlations with fibrosis (\n                      <jats:italic toggle=\"yes\">r<\/jats:italic>\n                      = \u20130.24,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.08). BMI independently predicted NASH (OR 1.44, 95% CI 1.13\u20131.84,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.004).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Decreased serum adropin and preptin levels may indicate hepatic disease severity and associated metabolic dysregulation independently of vascular changes. However, further studies are needed to define their clinical utility in NASH.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/njcp.njcp_509_25","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T03:00:28Z","timestamp":1774926028000},"page":"266-272","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Circulating Adropin and Preptin Levels in Non-alcoholic Steatohepatitis and Their Relationship with Carotid Intima Media Thickness: A Cross-Sectional Study from T\u00fcrkiye"],"prefix":"10.4103","volume":"29","author":[{"given":"BDO","family":"Coskun","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Healthy Sciences University, Ankara Bilkent City Hospital, Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"OS","family":"Dizdar","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Kayseri Training and Research Hospital, Kayseri, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Cak\u0131r","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Kayseri Training and Research Hospital, Kayseri, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Koc","sequence":"additional","affiliation":[{"name":"Department of Radiology, Kayseri Training and Research Hospital, Kayseri, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,3,31]]},"reference":[{"key":"R1-20260416","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/hep.29466","article-title":"Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease","volume":"67","author":"Estes","year":"2018","journal-title":"Hepatology"},{"key":"R2-20260416","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1186\/s12872-023-03580-6","article-title":"The association between metabolic dysfunction-associated steatotic liver disease, cardiovascular and cerebrovascular diseases and the thickness of carotid plaque","volume":"23","author":"Huang","year":"2023","journal-title":"BMC Cardiovasc Disord"},{"key":"R3-20260416","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/j.amjcard.2017.03.010","article-title":"Frequency of nonalcoholic fatty liver disease and subclinical atherosclerosis among young Mexican Americans","volume":"119","author":"Gill","year":"2017","journal-title":"Am J Cardiol"},{"key":"R4-20260416","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/MEG.0000000000000264","article-title":"Effects of ursodeoxycholic acid therapy on carotid intima media thickness, apolipoprotein A1, apolipoprotein B, and apolipoprotein B\/A1 ratio in nonalcoholic steatohepatitis","volume":"27","author":"Ozel Coskun","year":"2015","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R5-20260416","first-page":"42","article-title":"Association between nonalcoholic fatty liver disease and carotid intima-media thickness","volume":"174","author":"Vu","year":"2023","journal-title":"Clin Ter"},{"key":"R6-20260416","doi-asserted-by":"crossref","first-page":"978","DOI":"10.3390\/biomedicines13040978","article-title":"Hepatokine and proinflammatory cytokine profile in patients with carotid atherosclerosis and metabolic dysfunction-associated steatotic liver disease","volume":"13","author":"Cano-Contreras","year":"2025","journal-title":"Biomedicines"},{"key":"R7-20260416","doi-asserted-by":"crossref","first-page":"692642","DOI":"10.3389\/fphys.2021.692642","article-title":"New peptides as potential players in the crosstalk between the brain and obesity, metabolic and cardiovascular diseases","volume":"12","author":"Czerwi\u0144ska","year":"2021","journal-title":"Front Physiol"},{"issue":"Suppl 2","key":"R8-20260416","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.orcp.2017.03.001","article-title":"Relationship between plasma adropin levels and body composition and lipid characteristics amongst young adolescents in Taiwan","volume":"12","author":"Chang","year":"2018","journal-title":"Obes Res Clin Pract"},{"key":"R9-20260416","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1159\/000500106","article-title":"Serum adropin levels are reduced in adult patients with nonalcoholic fatty liver disease","volume":"28","author":"Kutlu","year":"2019","journal-title":"Med Princ Pract"},{"key":"R10-20260416","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.freeradbiomed.2020.08.005","article-title":"Lower adropin expression is associated with oxidative stress and severity of nonalcoholic fatty liver disease","volume":"160","author":"Chen","year":"2020","journal-title":"Free Radic Biol Med"},{"key":"R11-20260416","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.hlc.2015.03.008","article-title":"Serum adropin level in patients with stable coronary artery disease","volume":"24","author":"Zhao","year":"2015","journal-title":"Heart Lung Circ"},{"key":"R12-20260416","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.metabol.2019.06.005","article-title":"Adropin regulates cardiac energy metabolism and improves cardiac function and efficiency","volume":"98","author":"Altamimi","year":"2019","journal-title":"Metabolism"},{"key":"R13-20260416","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.peptides.2014.03.021","article-title":"Three new players in energy regulation: Preptin, adropin and irisin","volume":"56","author":"Aydin","year":"2014","journal-title":"Peptides"},{"key":"R14-20260416","first-page":"274","article-title":"Plasma preptin levels are decreased in patients with essential hypertension","volume":"73","author":"Cai","year":"2018","journal-title":"Pharmazie"},{"key":"R15-20260416","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"issue":"Suppl","key":"R16-20260416","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.3350\/cmh.2022.0365","article-title":"Global incidence and prevalence of nonalcoholic fatty liver disease","volume":"29","author":"Teng","year":"2023","journal-title":"Clin Mol Hepatol"},{"key":"R17-20260416","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S2468-1253(22)00317-X","article-title":"Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: A systematic review and meta-analysis","volume":"8","author":"Quek","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R18-20260416","doi-asserted-by":"crossref","first-page":"1120581","DOI":"10.3389\/fendo.2023.1120581","article-title":"Nonlinear correlation between fatty liver index and carotid intima media thickness among individuals undergoing health examination","volume":"14","author":"Zhou","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R19-20260416","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1139\/apnm-2014-0338","article-title":"Relationships between preptin and osteocalcin in obese, overweight, and normal weight adults","volume":"40","author":"El-Eshmawy","year":"2015","journal-title":"Appl Physiol Nutr Metab"},{"key":"R20-20260416","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1080\/07853890802244142","article-title":"Circulating preptin levels in normal, impaired glucose tolerance, and type 2 diabetic subjects","volume":"41","author":"Yang","year":"2009","journal-title":"Ann Med"},{"key":"R21-20260416","first-page":"1","article-title":"Plasma preptin levels in patients with type 2 diabetes mellitus","volume":"2","author":"Kalayc\u0131","year":"2019","journal-title":"Int J Med Biochem"},{"key":"R22-20260416","doi-asserted-by":"crossref","first-page":"628","DOI":"10.28982\/josam.859388","article-title":"Association of circulating preptin with non-alcoholic fatty liver disease: A case-control study","volume":"5","author":"Ar\u011fun","year":"2021","journal-title":"J Surg Med"},{"key":"R23-20260416","first-page":"1774","article-title":"Association between serum preptin level and \u0131nsulin resistance in patients with nonalcoholic fatty liver disease","volume":"32","author":"Jinjun","year":"2016","journal-title":"J Clin Hepatol"},{"key":"R24-20260416","doi-asserted-by":"crossref","first-page":"e19365","DOI":"10.1097\/MD.0000000000019365","article-title":"Association of polymorphisms of preptin, irisin and adropin genes with susceptibility to coronary artery disease and hypertension","volume":"99","author":"Wang","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"R25-20260416","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.cca.2018.06.038","article-title":"Preptin is a new predictor of coronary artery calcification","volume":"485","author":"Li","year":"2018","journal-title":"Clin Chim Acta"},{"key":"R26-20260416","doi-asserted-by":"crossref","first-page":"431","DOI":"10.32007\/jfacmedbaghdad.6642350","article-title":"Evaluation of preptin and other biomarkers in coronary artery disease patients with and without diabetes mellitus","volume":"66","author":"Yassen","year":"2024","journal-title":"J Fac Med Baghdad"},{"key":"R27-20260416","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.3892\/etm.2015.2954","article-title":"Adropin is associated with hyperhomocysteine and coronary atherosclerosis","volume":"11","author":"Zhao","year":"2016","journal-title":"Exp Ther Med"},{"key":"R28-20260416","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1515\/cclm-2013-0844","article-title":"Low serum adropin is associated with coronary atherosclerosis in type 2 diabetic and non-diabetic patients","volume":"52","author":"Wu","year":"2014","journal-title":"Clin Chem Lab Med"},{"key":"R29-20260416","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13098-022-00796-y","article-title":"The association between serum adropin and carotid atherosclerosis in patients with type 2 diabetes mellitus: A cross-sectional study","volume":"14","author":"Wei","year":"2022","journal-title":"Diabetol Metab Syndr"}],"container-title":["Nigerian Journal of Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/njcp.njcp_509_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T18:57:02Z","timestamp":1786647422000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/njcp.njcp_509_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/njcp.njcp_509_25","relation":{},"ISSN":["1119-3077","2229-7731"],"issn-type":[{"value":"1119-3077","type":"print"},{"value":"2229-7731","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"2025-07-29","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-19","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}